Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
04/06/2021 | Allena Pharmaceuticals, Inc. | ALNA | Grant | Stock Option (Right to Buy) | 74k | $1.31 | $96.9k | | 04/06/2021 |
12/04/2020 | CHIASMA, INC | CHMA | Exercise | Stock Option (Right to Buy) | 10k | $2.60 | $26k | | 12/04/2020 |
02/14/2020 | CHIASMA, INC | CHMA | Grant | Stock Option (Right to Buy) | 150k | $4.57 | $685.5k | | 02/14/2020 |
02/14/2019 | CHIASMA, INC | CHMA | Grant | Stock Option (Right to Buy) | 186k | $3.75 | $697.5k | | 02/14/2019 |
12/20/2018 | CHIASMA, INC | CHMA | Purchase | Common Stock | 9.6k | $2.50 | $24k | | 12/20/2018 |
02/23/2018 | CHIASMA, INC | CHMA | Grant | Stock Option (Right to Buy) | 194.2k | $1.52 | $295.2k | | 02/23/2018 |
02/23/2018 | CHIASMA, INC | CHMA | Grant | Stock Option (Right to Buy) | 68k | $1.52 | $103.3k | | 02/23/2018 |
02/10/2016 | CHIASMA, INC | CHMA | Grant | Stock Option (right to buy) | 70k | $9.93 | $695.1k | | 02/10/2016 |
08/19/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Purchase | Common Stock | 1.2k | $30.64 | $35.2k | | 08/19/2014 |
04/01/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Grant | Stock Option (right to buy) | 20k | $0.00 | $0 | | 04/01/2014 |
03/04/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Exercise | Stock Option (right to buy) | 2.5k | $17.64 | $44.1k | | 03/04/2014 |
02/10/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Exercise | Stock Option (right to buy) | 7.5k | $17.64 | $132.3k | | 02/10/2014 |
02/10/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 486 | $64.69 | $31.4k | | 02/10/2014 |
02/10/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 900 | $63.72 | $57.3k | | 02/10/2014 |
02/10/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 2.8k | $62.94 | $177.1k | | 02/10/2014 |
02/10/2014 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 3.3k | $61.71 | $203.6k | | 02/10/2014 |
11/13/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Exercise | Stock Option (right to buy) | 2.8k | $17.64 | $50.3k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Exercise | Stock Option (right to buy) | 7.5k | $17.64 | $132.3k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 1.8k | $80.03 | $144.1k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 4.5k | $79.34 | $355.3k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 622 | $78.38 | $48.8k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 200 | $76.14 | $15.2k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 200 | $74.43 | $14.9k | | 11/11/2013 |
11/11/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Sale | Common Stock | 200 | $73.01 | $14.6k | | 11/11/2013 |
08/26/2013 | Aegerion Pharmaceuticals, Inc. | AEGR | Exercise | Stock Option (right to buy) | 2.5k | $17.64 | $44.1k | | 08/26/2013 |